We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Alphabet Inc | NASDAQ:GOOGL | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.44 | 0.26% | 167.06 | 166.01 | 169.07 | 167.96 | 163.05 | 167.56 | 34,655,462 | 05:00:05 |
From May 2019 to May 2024
By Stephen Nakrosis
iRhythm Technologies, Inc. (IRTC) said Wednesday it would collaborate with Alphabet Inc.'s (GOOG) Verily to improve screening, diagnosis and management of patients with atrial fibrillation.
About one-third of people with atrial fibrillation are unaware they have it, the companies said, and about 20% of those who experience stroke due to atrial fibrillation weren't diagnosed until they had a stroke.
"The iRhythm and Verily collaboration aims to address this significant, underserved population at risk for asymptomatic or silent AFib," the companies said.
Under the terms of the deal, iRhythm will make an upfront payment to Verily of $5 million and potential milestone payments of up to $12.75 million upon the achievement of various development and regulatory milestones.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
September 04, 2019 17:38 ET (21:38 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Alphabet Chart |
1 Month Alphabet Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
